Skip to main content

Table 7 Gene expression data for fatty acid oxidation pathway genes in adipose from CL-316,243 treated MKR vs vehicle treated MKR mice

From: The beta-3 adrenergic agonist (CL-316,243) restores the expression of down-regulated fatty acid oxidation genes in type 2 diabetic mice

Gene name TR vs MKR Gene name TR vs MKR Gene name TR vs MKR
ALDH1A2 −5.1818 DCXR −1.6946 SLC27A1 NA
ALDH1A1 −4.1157 ACSL1 −1.5251 ACSL4 NA
SLC27A4 −3.8033 ADHFE1 1.52237 CPT2 NA
ALDH2 −3.7982 HSD17B4 1.54675 ACADM NA
CPT1A −3.6059 SLC27A6 1.60681 ACADL NA
ACSL5 −3.0073 ACAT1 1.89588 HSD17B8 NA
ACOX3 −2.7208 ACSBG2 1.89683 ACADVL NA
ALDH7A1 −2.5909 ADH6A 2.02657 EHHADH NA
ALDH3A2 −2.3444 ACAA1 2.02752 ECHS1 NA
IVD −2.2947 ACSL6 2.10495 HADHA NA
ACOX1 −2.0718 SLC27A5 2.51732 HADHB NA
ADH5 −1.9237 SDS 2.65876 HSD17B10 NA
CYP2E1 −1.7096 ACSBG1 NA   
  1. NA corresponds to that gene expression data was not available in the cut-off dataset (Fold-change > 1.5X and p-value < 0.05). TR denotes CL-316,243 treated MKR mice, MKR denotes vehicle treated MKR mice.